SEC Form 4 · accession 0001225208-16-036822
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heisz Leslie Stone
Director
Period of report
Jul 14, 2016
Accepted (ET)
Jul 18, 2016 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Acquire)F2,F1 | $107.03 | Jul 14, 2016 | A | 6,557 | A | Jul 14, 2017 | Jul 13, 2023 | Common Stock | 6,557 | 6,557 | D |
Explanation of responses
- F1This option was granted on July 14, 2016 under the Edwards Lifesciences Nonemployee Directors Stock Incentive Program and becomes exercisable 33% per year for three years commencing on the first anniversary of the grant date until fully vested.
- F2This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.